{"disease":{"id":"chordoma-squamous-with-rhabdoid-features","name":"Chordoma, Squamous with Rhabdoid Features","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Chordoma, Squamous with Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Undifferentiated Features and Rhabdoid Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}